Bachem acquires American Peptide Company

Bachem acquires American Peptide Company

February 27, 2015

Bubendorf/Basel, February 27, 2015 – Bachem (SIX:BANB), the leading peptide manufacturer, announced today the forthcoming acquisition of American Peptide Company, Inc. (APC), based in California, USA. The seller ILS, Inc. (Moriya, Japan), a wholly-owned subsidiary of Otsuka Chemical Co., Ltd. (Osaka, Japan), and the buyer, Bachem Americas, Inc. (Torrance, USA) have signed a contract to transfer all shares of APC. Both parties have agreed not to disclose the terms of the deal.